Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05ECA
|
||||
Former ID |
DIB009583
|
||||
Drug Name |
LJM716
|
||||
Drug Type |
Antibody
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 1/2 | [524764] | ||
Company |
Novartis pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | [532451] | ||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
EGF receptor signaling pathway | |||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
ErbB receptor signaling network | |||||
a6b1 and a6b4 Integrin signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.